ZSCAN18 and cancer: Initially, bioinformatics analysis of the data from The Cancer Genome Atlas (TCGA) datasets showed that expression of ZSCAN18 was depressed in a variety of cancers (Fig. 1A), and analysis from the public datasets (GSE33335) showed that ZSCAN18 is downregulated in GC samples (Fig. 1B).